In Brief: Syncor
This article was originally published in The Gray Sheet
Executive Summary
Syncor: Expects improved "margins and cash flow" as the result of revisions to its February 1994 distribution agreement with DuPont Merck's Radiopharmaceutical Division, in which Syncor became the principle distribution channel for DuPont's radiopharmaceutical products. On Jan. 6, Syncor began "preferential distribution" of DuPont's Neurolite, used in single photon emission computed tomography (SPECT) brain imaging. The Syncor/DuPont alliance resulted in "new incremental sales" of approximately $64 mil. for Syncor in 1994, the firm says...